Proposed Re-evaluation Decision PRVD2022-09, Bacillus amyloliquefaciens strain MBI600 and Bacillus subtilis strain QST 713 and the Associated End-use Products
Bacillus amyloliquefaciens strain MBI600 is a naturally occurring bacteria which suppresses plant diseases by preventing growth of pathogenic fungi through displacement and direct antagonistic action. All products containing Bacillus amyloliquefaciens strain MBI600 registered in Canada are subject to this proposed re-evaluation decision. The final re-evaluation decision will be published taking into consideration the comments and information received during the consultation period.
- Publisher
- Health Canada
- Resources
- 2
- Catalogue metadata updated
- 2023-05-31
Data overview
- Formats
- HTML
- File languages
- English, French
Official sources and licences
Resources
- Proposed Re-evaluation Decision PRVD2022-09, Bacillus amyloliquefaciens strain MBI600 and Bacillus subtilis strain QST 713 and the Associated End-use Products (French, HTML) HTML
- Proposed Re-evaluation Decision PRVD2022-09, Bacillus amyloliquefaciens strain MBI600 and Bacillus subtilis strain QST 713 and the Associated End-use Products (English, HTML) HTML